Conference
A Mutation-Independent CRISPR/Cas9-Based `Knockout and Replace' Strategy to Treat Rhodopsin-Associated Autosomal Dominant Retinitis Pigmentosa
Authors
Liu C-H; Wolf P; Dong R; Huang Y; Tabbaa D; Marco E; Duke B; Pinilla A; Pant A; D'Souza R
Volume
30
Pagination
pp. 572-573
Publisher
CELL PRESS
Publication Date
April 2022
Name of conference
25th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Conference place
DC, Washington
Conference start date
May 16, 2022
Conference end date
May 19, 2022
Conference proceedings
MOLECULAR THERAPY
Issue
4
ISSN
1525-0016